Sorry, this entry is only available in Ukrainian and Russian.
В Астані обговорили питання розвитку медико-фармацевтичних кластерів
Вас может заинтересовать:
WEB only
The main goals were to determine the extent to which FITOFARM is able to achieve effectiveness in the set goals and to find areas where improvement is needed. The organization…
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
